Upton, United Kingdom

Andrew Miller

This inventor holds 38 USPTO granted patents and 2 published patent applications and 14 EPO patents, primarily in Kinase Inhibitors. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2003-2016.

USPTO Granted Patents = 38 

% Patents Active = 26.3

 

Average Co-Inventor Count = 6.2

ph-index = 23

Forward Citations = 1,100(Granted Patents)


Location History:

  • Didcot, GB (2003 - 2009)
  • Oxfordshire, GB (2009 - 2010)
  • Upton, GB (2005 - 2015)
  • Abingdon, GB (2009 - 2015)
  • Upton Didcot, GB (2013 - 2016)

Company Filing History:


Years Active: 2003-2016

Loading Chart...
Loading Chart...
Areas of Expertise:
Kinase Inhibitors
Pyrazolopyridines
Aminopyrimidines
Substituted Pyrimidines
Caspase Inhibitors
Pyrazole Compounds
Tri-Cyclic Compounds
Azaindoles
Protein Kinases
Processes for Preparing
Compositions
Inhibitors
38 patents (USPTO):Explore Patents

Title: Andrew Miller - Innovative Inventor from Upton, GB

Introduction: Andrew Miller is a renowned inventor hailing from Upton, Great Britain, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Andrew Miller holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Andrew Miller has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Andrew Miller has collaborated with top universities, multinational companies, and fellow inventors to bring his ideas to life and make a lasting impact on the world of innovation.

Conclusion: Andrew Miller's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his reputation as a visionary inventor whose work continues to inspire future generations of innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…